SEC Form 4 · accession 0001127602-15-035177
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P Sheridan
Officer — Senior VP - CMO
Period of report
Dec 29, 2015
Accepted (ET)
Dec 31, 2015 · 2:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy)F1 | $10.82 | Dec 29, 2015 | A | 71,698 | A | Dec 29, 2016 | Dec 29, 2025 | Common Stock | 71,698 | 71,698 | D |
Explanation of responses
- F1Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.